Useful Links
Adult BNF Paediatric BNFBNF Apps (iOS and Android)
Further Medicines Management Resources
Antimicrobial guidelines
MHRA: Drug Safety Update (August 2018): Esmya (ulipristal acetate) risk of serious liver injury: new restrictions to use and requirements for liver function monitoring before, during, and after treatment
MHRA: Drug Safety Update (July 2018): Parenteral amphotericin B: risk of potentially fatal adverse reaction if formulations confused
MHRA: Drug Safety Update (July 2018): Eltrombopag (Revolade): reports of interference with bilirubin and creatinine test results
MHRA: Drug Safety Update (July 2018): Darunavir boosted with cobicistat: avoid use in pregnancy
MHRA: Drug Safety Update (June 2018): Denosumab (Xgeva▼) for advanced malignancies involving bone
MHRA: Drug Safety Update (June 2018): Denosumab (Xgeva) for giant cell tumour of bone: risk of clinically significant hypercalcaemia following discontinuation
